Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis

Michael J. Wagner; Seth M. Pollack; Lee D. Cranmer; Matthew J. Thompson; Shannon Maxwell; Stephanie Wright; Ali R. Khaki; Margaret M. Madeleine; Petros Grivas; Nicole M. Kuderer; Gary H. Lyman; Elizabeth T. Loggers

doi:10.1080/07357907.2021.1903914

Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis

Michael J. Wagner, Seth M. Pollack, Lee D. Cranmer, Matthew J. Thompson, Shannon Maxwell, Stephanie Wright, Ali R. Khaki, Margaret M. Madeleine, Petros Grivas, Nicole M. Kuderer, Gary H. Lyman, Elizabeth T. Loggers

Cancer Center

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24–69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6–41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20–62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.

Original language	English (US)
Pages (from-to)	315-320
Number of pages	6
Journal	Cancer Investigation
Volume	39
Issue number	4
DOIs	https://doi.org/10.1080/07357907.2021.1903914
State	Published - 2021

Keywords

COVID-19
Sarcoma
cohort Study

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1080/07357907.2021.1903914

Cite this

@article{5dfaf51ca05a4a8ea33ff36bf7a79436,

title = "Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis",

abstract = "Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24–69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6–41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20–62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.",

keywords = "COVID-19, Sarcoma, cohort Study",

author = "Wagner, {Michael J.} and Pollack, {Seth M.} and Cranmer, {Lee D.} and Thompson, {Matthew J.} and Shannon Maxwell and Stephanie Wright and Khaki, {Ali R.} and Madeleine, {Margaret M.} and Petros Grivas and Kuderer, {Nicole M.} and Lyman, {Gary H.} and Loggers, {Elizabeth T.}",

note = "Publisher Copyright: {\textcopyright} 2021 Taylor & Francis Group, LLC.",

year = "2021",

doi = "10.1080/07357907.2021.1903914",

language = "English (US)",

volume = "39",

pages = "315--320",

journal = "Cancer Investigation",

issn = "0735-7907",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Outcomes of Patients with Sarcoma and COVID-19 Infection

T2 - A Single Institution Cohort Analysis

AU - Wagner, Michael J.

AU - Pollack, Seth M.

AU - Cranmer, Lee D.

AU - Thompson, Matthew J.

AU - Maxwell, Shannon

AU - Wright, Stephanie

AU - Khaki, Ali R.

AU - Madeleine, Margaret M.

AU - Grivas, Petros

AU - Kuderer, Nicole M.

AU - Lyman, Gary H.

AU - Loggers, Elizabeth T.

PY - 2021

Y1 - 2021

N2 - Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24–69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6–41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20–62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.

AB - Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24–69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6–41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20–62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.

KW - COVID-19

KW - Sarcoma

KW - cohort Study

UR - http://www.scopus.com/inward/record.url?scp=85103238611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103238611&partnerID=8YFLogxK

U2 - 10.1080/07357907.2021.1903914

DO - 10.1080/07357907.2021.1903914

M3 - Article

C2 - 33720792

AN - SCOPUS:85103238611

SN - 0735-7907

VL - 39

SP - 315

EP - 320

JO - Cancer Investigation

JF - Cancer Investigation

IS - 4

ER -

Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this